Gender differences and the effects of ketamine in healthy volunteers.
We present a critical perspective of the impact of gender differences on a widely accepted model of ketamine psychosis in healthy volunteers. Male and female patients with schizophrenia present with different symptomatology, disease course and response to pharmacological intervention. Accordingly, it is expected that ketamine psychosis in healthy volunteers fulfils this face validity. Pre-clinical studies in rats indicate a gender difference in response to ketamine administration. However, a review of the literature to date indicates that studies carried out in healthy volunteers have used all male or mixed samples, indicating the need for further studies comparing the psychopathological effects of ketamine in males and females.
Lees
Jane
J
Neuroscience and Psychiatry Unit, School of Psychiatry and Behavioural Science, University of Manchester, UK.
Hallak
Jaime E C
JE
Deakin
John F W
JF
Dursun
Serdar M
SM
D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007649:Ketamine; D008297:Male; D011605:Psychoses, Substance-Induced / Q000209:etiology / Q000503:physiopathology*; D051381:Rats; D012737:Sex Factors
D007649:Ketamine